Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 43601-43650 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06759961
Post-transplant Thrombotic Microangiopathy: Evaluation of Outcomes at the Bologna Kidney Transplant Centre
N/ARecruiting
250 participants
Started: Feb 1, 2023 · Completed: Feb 1, 2033
2 conditions1 sponsor1 location
NCT05732389
Immunotherapy in Patients With Early dMMR Rectal Cancer
PHASE2Recruiting
39 participants
Started: Feb 1, 2023 · Completed: Feb 29, 2052
1 condition8 sponsors5 locations
NCT05652673
Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial
NARecruiting
80 participants
Started: Feb 1, 2023 · Completed: Dec 1, 2029
4 conditions1 sponsor1 location
NCT05567068
Atorvastatin Efficacy and Safety in Patients With Ulcerative Colitis
PHASE2Recruiting
44 participants
Started: Feb 1, 2023 · Completed: Sep 20, 2027
1 condition1 sponsor1 location
NCT05171686
Diuretics and Volume Overload in Early CKD
PHASE4Recruiting
46 participants
Started: Feb 1, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05728957
Renal Mass Biopsy, PEER, and 99mTc-sestamibi SPECT/CT for Patients With Clinically Localized Renal Tumors
N/ARecruiting
100 participants
Started: Feb 1, 2023 · Completed: Dec 31, 2033
3 conditions1 sponsor1 location
NCT05734274
Clinical Effects of Limosilactobacillus Reuteri Probiotics as an Adjunct to the Treatment of Periodontitis
NARecruiting
60 participants
Started: Feb 1, 2023 · Completed: Jul 31, 2024
1 condition1 sponsor1 location
NCT05884983
Screening Effect of Dual-energy CT Combined With Nasopharyngeal Endoscopy for Screening Nasopharyngeal Carcinoma
N/ARecruiting
12,000 participants
Started: Feb 1, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05719519
Change in Gingival Volume and Quality of Life Due to Initial Periodontal Therapy in Smokers
NARecruiting
60 participants
Started: Feb 1, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05193305
Study of Healthy Cohort for Early Detection of Cancer
N/ARecruiting
10,000 participants
Started: Feb 1, 2023 · Completed: Feb 28, 2043
1 condition2 sponsors1 location
NCT05419726
Brown Adipose Tissue Activity in Response to Semaglutide Administered to Obese Subjects.
N/ARecruiting
20 participants
Started: Feb 1, 2023 · Completed: Feb 1, 2026
1 condition1 sponsor1 location
NCT05464368
R21 Roche: 3-Way Tau Tracers in AD
PHASE1Recruiting
38 participants
Started: Feb 1, 2023 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT05738720
Effect of Home Based Pulmonary Rehabilitation on Exacerbation and Hospital Admission in Severe COPD
NARecruiting
24 participants
Started: Feb 1, 2023 · Completed: Dec 20, 2026
1 condition1 sponsor1 location
NCT06330675
Correct Mobilization Time After Implantation of an Intracardiac Electronic Device Implantation
NARecruiting
558 participants
Started: Feb 1, 2023 · Completed: Jun 1, 2027
2 conditions2 sponsors1 location
NCT05643209
Brugada Syndrome Substrate Characterization and Ablation
NARecruiting
20 participants
Started: Feb 1, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT04433052
Clinical Value and Cost-effectiveness of a Personalized Prevention Program (PPP) in Patients With High Risk Stable CHD
NARecruiting
12,000 participants
Started: Feb 1, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor26 locations
NCT06243432
Estrogen Receptors and HER2 Levels' Expression in Luminal Metastatic Breast Cancer
N/ARecruiting
600 participants
Started: Feb 1, 2023 · Completed: Mar 1, 2025
1 condition1 sponsor1 location
NCT05362370
Stryker PEEK Customized Implant: A Prospective Post Market Follow Up to Evaluate Safety, Performance and Effectiveness
N/ARecruiting
110 participants
Started: Feb 1, 2023 · Completed: Dec 30, 2027
3 conditions2 sponsors13 locations
NCT05370118
Improving Physical Activity With Cognitive Impairment
NARecruiting
60 participants
Started: Feb 1, 2023 · Completed: Jun 30, 2025
2 conditions2 sponsors1 location
NCT05509166
Affirmative Psychotherapy for Sexual Minority Women's Mental and Behavioral Health
NARecruiting
450 participants
Started: Feb 1, 2023 · Completed: Aug 1, 2027
2 conditions2 sponsors1 location
NCT05498272
Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations
PHASE2Recruiting
32 participants
Started: Feb 1, 2023 · Completed: Dec 31, 2026
5 conditions3 sponsors6 locations
NCT05751733
Apatinib Mesylate Versus Standard Second-line TKI in the Treatment of Advanced GIST
NARecruiting
258 participants
Started: Feb 1, 2023 · Completed: Jan 1, 2027
1 condition2 sponsors1 location
NCT06455072
Nituzumab Plus Serplulimab Combined With SBRT in Cervical Cancer
PHASE2Recruiting
37 participants
Started: Feb 1, 2023 · Completed: Jan 31, 2025
1 condition2 sponsors1 location
NCT05779254
SURGIcal COmplication and MIcrobiome ChangeS in Colorectal Surgery
N/ARecruiting
100 participants
Started: Feb 1, 2023 · Completed: Jan 31, 2026
2 conditions3 sponsors3 locations
NCT05688020
Tranexamic Acid During Upper GI Endoscopic Resection Procedures
PHASE4Recruiting
200 participants
Started: Feb 1, 2023 · Completed: Feb 28, 2026
4 conditions1 sponsor1 location
NCT05785793
Autoimmune Hepatitis Cohort in China
N/ARecruiting
1,000 participants
Started: Feb 1, 2023 · Completed: Feb 1, 2028
1 condition1 sponsor1 location
NCT06241105
Lenvatinib Plus Toripalimab for Platinum-Resistant Recurrent Ovarian Cancer
PHASE2Recruiting
69 participants
Started: Feb 1, 2023 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT06976073
Non-invasive Imaging for In-vivo Quantification of Skin Composition and Structure
N/ARecruiting
8,000 participants
Started: Feb 1, 2023 · Completed: Jan 1, 2026
5 conditions1 sponsor3 locations
NCT05327686
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
PHASE2Recruiting
240 participants
Started: Feb 1, 2023 · Completed: Jun 15, 2028
4 conditions2 sponsors258 locations
NCT05708001
Improvement of Memory in Mild Cognitive Impairment
NARecruiting
40 participants
Started: Feb 1, 2023 · Completed: Dec 1, 2027
1 condition1 sponsor1 location
NCT05279287
Video Analysis of Errors and Technical Performance Within Minimally Invasive Surgery Short Title: Video Analysis in Minimally Invasive Surgery (VAMIS)
N/ARecruiting
100 participants
Started: Feb 1, 2023 · Completed: Aug 31, 2024
2 conditions3 sponsors5 locations
NCT05222958
Effectiveness of an App for Tobacco Cessation in Pregnant Women (TOBBGEST)
NARecruiting
400 participants
Started: Feb 1, 2023 · Completed: May 30, 2026
1 condition3 sponsors1 location
NCT05154253
Augmenting Ankle Plantarflexor Function in Cerebral Palsy
PHASE1Recruiting
36 participants
Started: Feb 1, 2023 · Completed: Sep 25, 2026
1 condition3 sponsors1 location
NCT06453538
Sleep Quality and Sleep-disordered Breathing in Bypass Surgery Patients
N/ARecruiting
54 participants
Started: Feb 1, 2023 · Completed: Dec 30, 2025
2 conditions1 sponsor1 location
NCT06585722
Association Between Venous Excess Ultrasound Grading System and Acute Kidney Injury in the ICU Population
N/ARecruiting
136 participants
Started: Feb 1, 2023 · Completed: Sep 5, 2024
3 conditions1 sponsor1 location
NCT05748717
Arterial Function Parameters and Transcranial Doppler Velocity in Paediatric Patients With Sickle Cell Disease
N/ARecruiting
34 participants
Started: Feb 1, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05295212
Atezolizumab Combined With Platinum-based Chemotherapy as Neoadjuvant Therapy for Patients With Resectable Stage II-IIIB
PHASE2Recruiting
120 participants
Started: Feb 1, 2023 · Completed: Jul 1, 2025
1 condition1 sponsor1 location
NCT06998381
Ethnic Specificities of S100B Protein Blood Level in Guadeloupe: Cross-sectional Study in Healthy Subjects
N/ARecruiting
200 participants
Started: Feb 1, 2023 · Completed: Aug 1, 2025
1 condition1 sponsor2 locations
NCT05730023
A Multimodal Approach for Clinical Diagnosis and Treatment of Primary Progressive Aphasia, MAINSTREAM ID:3430931
NARecruiting
60 participants
Started: Feb 1, 2023 · Completed: Feb 28, 2026
1 condition5 sponsors4 locations
NCT05745181
Clinical Study of Anti-CD1a CAR-T in the Treatment of R/R Acute T-lymphoblastic Leukemia/Lymphoblastic Lymphoma
PHASE2Recruiting
20 participants
Started: Feb 1, 2023 · Completed: Jan 1, 2026
2 conditions1 sponsor1 location
NCT06992011
A Randomized Controlled Trial Comparing Clinical Effectiveness of SMILE Versus SMILE Xtra in Myopia
NARecruiting
300 participants
Started: Feb 1, 2023 · Completed: Feb 28, 2027
1 condition1 sponsor1 location
NCT05723003
Prospective Validation of an Acute Pulmonary Embolism Severity and Prognosis Prediction Model
N/ARecruiting
4,000 participants
Started: Feb 1, 2023 · Completed: Oct 30, 2025
1 condition1 sponsor1 location
NCT05704582
RCT Comparing Avatar Intervention to Supportive Intervention to Reduce Cannabis Use in Patients With Psychotic Disorders
NARecruiting
150 participants
Started: Feb 1, 2023 · Completed: Jan 31, 2028
3 conditions2 sponsors1 location
NCT05874310
Gene Therapy for Subjects With RPGR Mutation-associated X-linked Retinitis Pigmentosa
EARLY_PHASE1Recruiting
18 participants
Started: Feb 1, 2023 · Completed: Nov 1, 2027
1 condition4 sponsors2 locations
NCT05891145
Remimazolam for Postoperative Atrial Fibrillation
NARecruiting
50 participants
Started: Feb 1, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT06600945
Atracurium Versus Atracurium and Magnesium Sulphate As Adjuvants to Local Anesthetic
N/ARecruiting
180 participants
Started: Feb 1, 2023 · Completed: Apr 1, 2025
1 condition2 sponsors1 location
NCT06067607
Examining the Effect of Eye Gaze Technology on Children With Cortical Visual Impairment
NARecruiting
10 participants
Started: Feb 1, 2023 · Completed: Apr 5, 2024
2 conditions1 sponsor1 location
NCT06508866
Timing And Typology of ConducTIon disturbanCes During TAVI
N/ARecruiting
490 participants
Started: Feb 1, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05821166
Potential of Moderate Whole Body Hyperthermia to Enhance Response
PHASE2Recruiting
80 participants
Started: Feb 1, 2023 · Completed: Dec 1, 2027
1 condition1 sponsor1 location
NCT05673031
68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors
N/ARecruiting
500 participants
Started: Feb 1, 2023 · Completed: Jan 1, 2027
1 condition1 sponsor1 location